{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:38:13Z","timestamp":1789713493339,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"crossref","award":["2014A030310292"],"award-info":[{"award-number":["2014A030310292"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Program of Guangdong Province","award":["2013B021800079"],"award-info":[{"award-number":["2013B021800079"]}]},{"name":"Major project of Guangzhou healthcare innovation","award":["201400000003-4"],"award-info":[{"award-number":["201400000003-4"]}]},{"name":"Collaborative fund with Sun Yat-sen University Cancer Center 973 project","award":["2012CB967000"],"award-info":[{"award-number":["2012CB967000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12967-016-1012-8","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T21:14:01Z","timestamp":1474319641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells"],"prefix":"10.1186","volume":"14","author":[{"given":"Ying","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Bin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Jie","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"key":"1012_CR1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","volume":"243","author":"JD Rowley","year":"1973","unstructured":"Rowley JD. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature. 1973;243:290\u20133.","journal-title":"Nature"},{"key":"1012_CR2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","volume":"36","author":"J Groffen","year":"1984","unstructured":"Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell. 1984;36:93\u20139.","journal-title":"Cell"},{"key":"1012_CR3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1056\/NEJMra013339","volume":"346","author":"DG Savage","year":"2002","unstructured":"Savage DG, Antman KH. Imatinib mesylate\u2014a new oral targeted therapy. N Engl J Med. 2002;346:683\u201393.","journal-title":"N Engl J Med"},{"key":"1012_CR4","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood-2014-10-567784","volume":"125","author":"AJ Barrett","year":"2015","unstructured":"Barrett AJ, Ito S. The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century. Blood. 2015;125:3230\u20135.","journal-title":"Blood"},{"key":"1012_CR5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00062752-200207000-00007","volume":"9","author":"ME Gorre","year":"2002","unstructured":"Gorre ME, Sawyers CL. Molecular mechanisms of resistance to STI571 in chronic myeloid leukemia. Curr Opin Hematol. 2002;9:303\u20137.","journal-title":"Curr Opin Hematol"},{"key":"1012_CR6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1051\/medsci\/20143004022","volume":"30","author":"JC Chomel","year":"2014","unstructured":"Chomel JC, Aggoune D, Sorel N, Turhan AG. Chronic myeloid leukemia stem cells: cross-talk with the niche. Med Sci (Paris). 2014;30:452\u201361.","journal-title":"Med Sci (Paris)"},{"key":"1012_CR7","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1158\/0008-5472.CAN-04-1795","volume":"64","author":"JI Johnsen","year":"2004","unstructured":"Johnsen JI, Lindskog M, Ponthan F, Pettersen I, Elfman L, Orrego A, Sveinbjornsson B, Kogner P. Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo. Cancer Res. 2004;64:7210\u20135.","journal-title":"Cancer Res"},{"key":"1012_CR8","first-page":"2006","volume":"6","author":"T Hida","year":"2000","unstructured":"Hida T, Kozaki K, Muramatsu H, Masuda A, Shimizu S, Mitsudomi T, Sugiura T, Ogawa M, Takahashi T. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res. 2000;6:2006\u201311.","journal-title":"Clin Cancer Res"},{"key":"1012_CR9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ijrobp.2003.09.061","volume":"58","author":"E Nakata","year":"2004","unstructured":"Nakata E, Mason KA, Hunter N, Husain A, Raju U, Liao Z, Ang KK, Milas L. Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors. Int J Radiat Oncol Biol Phys. 2004;58:369\u201375.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1012_CR10","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","volume":"342","author":"G Steinbach","year":"2000","unstructured":"Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000;342:1946\u201352.","journal-title":"N Engl J Med"},{"key":"1012_CR11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/JTO.0b013e31821529a9","volume":"6","author":"NK Altorki","year":"2011","unstructured":"Altorki NK, Christos P, Port JL, Lee PC, Mirza F, Spinelli C, Keresztes R, Beneck D, Paul S, Stiles BM, et al. Preoperative taxane-based chemotherapy and celecoxib for carcinoma of the esophagus and gastroesophageal junction: results of a phase 2 trial. J Thorac Oncol. 2011;6:1121\u20137.","journal-title":"J Thorac Oncol"},{"key":"1012_CR12","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3748\/wjg.v11.i13.1896","volume":"11","author":"TC Tang","year":"2005","unstructured":"Tang TC, Poon RT, Lau CP, Xie D, Fan ST. Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma. World J Gastroenterol. 2005;11:1896\u2013902.","journal-title":"World J Gastroenterol"},{"key":"1012_CR13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1517\/13543784.2013.766715","volume":"22","author":"LW Chow","year":"2013","unstructured":"Chow LW, Tung SY, Ng TY, Im SA, Lee MH, Yip AY, Toi M, Gluck S. Concurrent celecoxib with 5-fluorouracil\/epirubicin\/cyclophosphamide followed by docetaxel for stages II - III invasive breast cancer: the OOTR-N001 study. Expert Opin Invest Drugs. 2013;22:299\u2013307.","journal-title":"Expert Opin Invest Drugs"},{"key":"1012_CR14","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1200\/JCO.2003.07.127","volume":"21","author":"NK Altorki","year":"2003","unstructured":"Altorki NK, Keresztes RS, Port JL, Libby DM, Korst RJ, Flieder DB, Ferrara CA, Yankelevitz DF, Subbaramaiah K, Pasmantier MW, Dannenberg AJ. Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer. J Clin Oncol. 2003;21:2645\u201350.","journal-title":"J Clin Oncol"},{"key":"1012_CR15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/jpet.107.131383","volume":"324","author":"A Mehar","year":"2008","unstructured":"Mehar A, Macanas-Pirard P, Mizokami A, Takahashi Y, Kass GE, Coley HM. The effects of cyclooxygenase-2 expression in prostate cancer cells: modulation of response to cytotoxic agents. J Pharmacol Exp Ther. 2008;324:1181\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"1012_CR16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4161\/auto.6.2.11124","volume":"6","author":"S Huang","year":"2010","unstructured":"Huang S, Sinicrope FA. Celecoxib-induced apoptosis is enhanced by ABT-737 and by inhibition of autophagy in human colorectal cancer cells. Autophagy. 2010;6:256\u201369.","journal-title":"Autophagy"},{"key":"1012_CR17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1476-4598-8-66","volume":"8","author":"KB Kang","year":"2009","unstructured":"Kang KB, Zhu C, Yong SK, Gao Q, Wong MC. Enhanced sensitivity of celecoxib in human glioblastoma cells: induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy. Mol Cancer. 2009;8:66.","journal-title":"Mol Cancer"},{"key":"1012_CR18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0145-2126(03)00183-8","volume":"28","author":"T Wun","year":"2004","unstructured":"Wun T, McKnight H, Tuscano JM. Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma. Leuk Res. 2004;28:179\u201390.","journal-title":"Leuk Res"},{"key":"1012_CR19","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.3109\/10428194.2013.781170","volume":"54","author":"C Chen","year":"2013","unstructured":"Chen C, Xu W, Wang CM. Combination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia cells. Leuk Lymphoma. 2013;54:2517\u201322.","journal-title":"Leuk Lymphoma"},{"key":"1012_CR20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.leukres.2007.11.007","volume":"32","author":"KM Arunasree","year":"2008","unstructured":"Arunasree KM, Roy KR, Anilkumar K, Aparna A, Reddy GV, Reddanna P. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. Leuk Res. 2008;32:855\u201364.","journal-title":"Leuk Res"},{"key":"1012_CR21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ajh.20542","volume":"81","author":"GS Zhang","year":"2006","unstructured":"Zhang GS, Liu DS, Dai CW, Li RJ. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Am J Hematol. 2006;81:242\u201355.","journal-title":"Am J Hematol"},{"key":"1012_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132:27\u201342.","journal-title":"Cell"},{"key":"1012_CR23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nm1574","volume":"13","author":"A Nakai","year":"2007","unstructured":"Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, Taniike M, Omiya S, Mizote I, Matsumura Y, Asahi M, et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med. 2007;13:619\u201324.","journal-title":"Nat Med"},{"key":"1012_CR24","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1523\/JNEUROSCI.2261-06.2006","volume":"26","author":"QJ Wang","year":"2006","unstructured":"Wang QJ, Ding Y, Kohtz DS, Mizushima N, Cristea IM, Rout MP, Chait BT, Zhong Y, Heintz N, Yue Z. Induction of autophagy in axonal dystrophy and degeneration. J Neurosci. 2006;26:8057\u201368.","journal-title":"J Neurosci"},{"key":"1012_CR25","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1158\/1541-7786.MCR-13-0172","volume":"11","author":"LL Liu","year":"2013","unstructured":"Liu LL, Long ZJ, Wang LX, Zheng FM, Fang ZG, Yan M, Xu DF, Chen JJ, Wang SW, Lin DJ, Liu Q. Inhibition of mTOR pathway sensitizes acute myeloid leukemia cells to aurora inhibitors by suppression of glycolytic metabolism. Mol Cancer Res. 2013;11:1326\u201336.","journal-title":"Mol Cancer Res"},{"key":"1012_CR26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2239","volume":"8","author":"MC Maiuri","year":"2007","unstructured":"Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol. 2007;8:741\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1012_CR27","doi-asserted-by":"crossref","first-page":"e82034","DOI":"10.1371\/journal.pone.0082034","volume":"8","author":"KH Huang","year":"2013","unstructured":"Huang KH, Kuo KL, Ho IL, Chang HC, Chuang YT, Lin WC, Lee PY, Chang SC, Chiang CK, Pu YS, et al. Celecoxib-induced cytotoxic effect is potentiated by inhibition of autophagy in human urothelial carcinoma cells. PLoS One. 2013;8:e82034.","journal-title":"PLoS One"},{"key":"1012_CR28","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","volume":"19","author":"Y Kabeya","year":"2000","unstructured":"Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19:5720\u20138.","journal-title":"EMBO J"},{"key":"1012_CR29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0076-6879(08)03612-4","volume":"452","author":"G Bjorkoy","year":"2009","unstructured":"Bjorkoy G, Lamark T, Pankiv S, Overvatn A, Brech A, Johansen T. Monitoring autophagic degradation of p62\/SQSTM1. Methods Enzymol. 2009;452:181\u201397.","journal-title":"Methods Enzymol"},{"key":"1012_CR30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","volume":"584","author":"CH Jung","year":"2010","unstructured":"Jung CH, Ro SH, Cao J, Otto NM, Kim DH. mTOR regulation of autophagy. FEBS Lett. 2010;584:1287\u201395.","journal-title":"FEBS Lett"},{"key":"1012_CR31","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.1167\/iovs.10-5278","volume":"51","author":"YH Yoon","year":"2010","unstructured":"Yoon YH, Cho KS, Hwang JJ, Lee SJ, Choi JA, Koh JY. Induction of lysosomal dilatation, arrested autophagy, and cell death by chloroquine in cultured ARPE-19 cells. Invest Ophthalmol Vis Sci. 2010;51:6030\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1012_CR32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/cyto.a.22312","volume":"85","author":"S Chikte","year":"2014","unstructured":"Chikte S, Panchal N, Warnes G. Use of LysoTracker dyes: a flow cytometric study of autophagy. Cytometry A. 2014;85:169\u201378.","journal-title":"Cytometry A"},{"key":"1012_CR33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0076-6879(08)04007-X","volume":"453","author":"M Bains","year":"2009","unstructured":"Bains M, Heidenreich KA. Live-cell imaging of autophagy induction and autophagosome-lysosome fusion in primary cultured neurons. Methods Enzymol. 2009;453:145\u201358.","journal-title":"Methods Enzymol"},{"key":"1012_CR34","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1016\/j.biomaterials.2010.04.048","volume":"31","author":"JO You","year":"2010","unstructured":"You JO, Auguste DT. The effect of swelling and cationic character on gene transfection by pH-sensitive nanocarriers. Biomaterials. 2010;31:6859\u201366.","journal-title":"Biomaterials"},{"key":"1012_CR35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/cncr.26225","volume":"118","author":"DL Gibbons","year":"2012","unstructured":"Gibbons DL, Pricl S, Kantarjian H, Cortes J, Quintas-Cardama A. The rise and fall of gatekeeper mutations? The BCR-ABL1 T315I paradigm. Cancer. 2012;118:293\u20139.","journal-title":"Cancer"},{"key":"1012_CR36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4161\/cbt.11.2.14622","volume":"11","author":"N Chen","year":"2011","unstructured":"Chen N, Karantza V. Autophagy as a therapeutic target in cancer. Cancer Biol Ther. 2011;11:157\u201368.","journal-title":"Cancer Biol Ther"},{"key":"1012_CR37","doi-asserted-by":"crossref","first-page":"24131","DOI":"10.1074\/jbc.M702824200","volume":"282","author":"S Pankiv","year":"2007","unstructured":"Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T. p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem. 2007;282:24131\u201345.","journal-title":"J Biol Chem"},{"key":"1012_CR38","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2009.03.048","volume":"137","author":"R Mathew","year":"2009","unstructured":"Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell. 2009;137:1062\u201375.","journal-title":"Cell"},{"key":"1012_CR39","first-page":"9","volume":"68","author":"G Warnes","year":"2014","unstructured":"Warnes G. Measurement of autophagy by flow cytometry. Curr Protoc Cytom. 2014;68:9\u201345.","journal-title":"Curr Protoc Cytom"},{"key":"1012_CR40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.2042-7158.2011.01371.x","volume":"64","author":"J Liu","year":"2012","unstructured":"Liu J, Hu XJ, Jin B, Qu XJ, Hou KZ, Liu YP. \u03b2-Elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cells. J Pharm Pharmacol. 2012;64:146\u201353.","journal-title":"J Pharm Pharmacol"},{"key":"1012_CR41","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1158\/1078-0432.CCR-07-5023","volume":"15","author":"E White","year":"2009","unstructured":"White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Cancer Res. 2009;15:5308\u201316.","journal-title":"Clin Cancer Res"},{"key":"1012_CR42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","volume":"99","author":"SM Graham","year":"2002","unstructured":"Graham SM, Jorgensen HG, Allan E, Pearson C, Alcorn MJ, Richmond L, Holyoake TL. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood. 2002;99:319\u201325.","journal-title":"Blood"},{"key":"1012_CR43","doi-asserted-by":"crossref","first-page":"9624","DOI":"10.1158\/0008-5472.CAN-08-1131","volume":"68","author":"H Konig","year":"2008","unstructured":"Konig H, Copland M, Chu S, Jove R, Holyoake TL, Bhatia R. Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells. Cancer Res. 2008;68:9624\u201333.","journal-title":"Cancer Res"},{"key":"1012_CR44","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1182\/blood-2011-01-330621","volume":"118","author":"GV Helgason","year":"2011","unstructured":"Helgason GV, Karvela M, Holyoake TL. Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML. Blood. 2011;118:2035\u201343.","journal-title":"Blood"},{"key":"1012_CR45","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2010-12-322537","volume":"118","author":"Z Sheng","year":"2011","unstructured":"Sheng Z, Ma L, Sun JE, Zhu LJ, Green MR. BCR-ABL suppresses autophagy through ATF5-mediated regulation of mTOR transcription. Blood. 2011;118:2840\u20138.","journal-title":"Blood"},{"key":"1012_CR46","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/leu.2012.65","volume":"26","author":"Y Yu","year":"2012","unstructured":"Yu Y, Yang L, Zhao M, Zhu S, Kang R, Vernon P, Tang D, Cao L. Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells. Leukemia. 2012;26:1752\u201360.","journal-title":"Leukemia"},{"key":"1012_CR47","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4161\/auto.5.7.9509","volume":"5","author":"P Salomoni","year":"2009","unstructured":"Salomoni P, Calabretta B. Targeted therapies and autophagy: new insights from chronic myeloid leukemia. Autophagy. 2009;5:1050\u20131.","journal-title":"Autophagy"},{"key":"1012_CR48","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1349-7006.2008.00932.x","volume":"99","author":"Y Mishima","year":"2008","unstructured":"Mishima Y, Terui Y, Mishima Y, Taniyama A, Kuniyoshi R, Takizawa T, Kimura S, Ozawa K, Hatake K. Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors. Cancer Sci. 2008;99:2200\u20138.","journal-title":"Cancer Sci"},{"key":"1012_CR49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajh.21914","volume":"86","author":"LC Crowley","year":"2011","unstructured":"Crowley LC, Elzinga BM, O\u2019Sullivan GC, McKenna SL. Autophagy induction by Bcr-Abl-expressing cells facilitates their recovery from a targeted or nontargeted treatment. Am J Hematol. 2011;86:38\u201347.","journal-title":"Am J Hematol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-016-1012-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T01:43:38Z","timestamp":1589679818000},"score":1,"resource":{"primary":{"URL":"http:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-016-1012-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1186\/s12967-016-1012-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]},"article-number":"270"}}